PL401225A1 - Preparat zapobiegajacy masowemu wymieraniu owadów z rodziny pszczolowatych (Apidae) oraz zastosowania tego preparatu - Google Patents

Preparat zapobiegajacy masowemu wymieraniu owadów z rodziny pszczolowatych (Apidae) oraz zastosowania tego preparatu

Info

Publication number
PL401225A1
PL401225A1 PL401225A PL40122512A PL401225A1 PL 401225 A1 PL401225 A1 PL 401225A1 PL 401225 A PL401225 A PL 401225A PL 40122512 A PL40122512 A PL 40122512A PL 401225 A1 PL401225 A1 PL 401225A1
Authority
PL
Poland
Prior art keywords
product
apidae
insects
preventing
bee family
Prior art date
Application number
PL401225A
Other languages
English (en)
Other versions
PL219703B1 (pl
Inventor
Mariusz Gagos
Original Assignee
Bioactive-Tech Spólka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioactive-Tech Spólka Z Ograniczona Odpowiedzialnoscia filed Critical Bioactive-Tech Spólka Z Ograniczona Odpowiedzialnoscia
Priority to PL401225A priority Critical patent/PL219703B1/pl
Publication of PL401225A1 publication Critical patent/PL401225A1/pl
Priority to PCT/IB2013/001829 priority patent/WO2014060803A1/en
Priority to US14/436,343 priority patent/US20150283098A1/en
Priority to EP13776551.7A priority patent/EP2908634A1/en
Publication of PL219703B1 publication Critical patent/PL219703B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
    • C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Preparat zapobiegajacy masowemu wymieraniu owadów z rodziny pszczolowatych (Apidae) w nastepstwie wystepowania syndromu Colony Collapse Disorder (CCD), charakteryzuje sie tym, ze zawiera prenylowa pochodna chalkonu lub jej metabolity, rozpuszczalnik oraz syrop cukrowy o stezeniu prenylowej pochodnej chalkonu lub jej metabolitu 0,001-1000 mg/1 preparatu i ewentualnie dopuszczalne w pszczelarstwie substancje dodatkowe.
PL401225A 2012-10-16 2012-10-16 Preparat zapobiegający masowemu wymieraniu owadów z rodziny pszczołowatych (Apidae) oraz zastosowania tego preparatu PL219703B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL401225A PL219703B1 (pl) 2012-10-16 2012-10-16 Preparat zapobiegający masowemu wymieraniu owadów z rodziny pszczołowatych (Apidae) oraz zastosowania tego preparatu
PCT/IB2013/001829 WO2014060803A1 (en) 2012-10-16 2013-08-22 Prenylated chalcone formulation for the treatment of bees
US14/436,343 US20150283098A1 (en) 2012-10-16 2013-08-22 Prenylated chalcone formulation for the treatment of bees
EP13776551.7A EP2908634A1 (en) 2012-10-16 2013-08-22 Prenylated chalcone formulation for the treatment of bees

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL401225A PL219703B1 (pl) 2012-10-16 2012-10-16 Preparat zapobiegający masowemu wymieraniu owadów z rodziny pszczołowatych (Apidae) oraz zastosowania tego preparatu

Publications (2)

Publication Number Publication Date
PL401225A1 true PL401225A1 (pl) 2013-07-22
PL219703B1 PL219703B1 (pl) 2015-06-30

Family

ID=48877692

Family Applications (1)

Application Number Title Priority Date Filing Date
PL401225A PL219703B1 (pl) 2012-10-16 2012-10-16 Preparat zapobiegający masowemu wymieraniu owadów z rodziny pszczołowatych (Apidae) oraz zastosowania tego preparatu

Country Status (4)

Country Link
US (1) US20150283098A1 (pl)
EP (1) EP2908634A1 (pl)
PL (1) PL219703B1 (pl)
WO (1) WO2014060803A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6580967B2 (ja) * 2015-12-01 2019-09-25 大日本除蟲菊株式会社 ゴキブリ集合誘引物質、ゴキブリ集合誘引剤及びゴキブリ駆除剤
TWI698245B (zh) * 2017-08-18 2020-07-11 彥臣生技藥品股份有限公司 用於提升昆蟲免疫力之組合物及方法
WO2021046388A1 (en) * 2019-09-06 2021-03-11 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for cognitive protection of pollinators against pesticides
CN119014403B (zh) * 2024-10-29 2025-03-21 山东尚农农业科技有限公司 一种纳米农药制剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156950A1 (en) * 2001-04-05 2004-08-12 Green Martin Richard Use of hop components in foods
ATE321124T1 (de) * 2002-12-18 2006-04-15 Doehler Gmbh Xanthohumol-haltiges getränk
DE102004063125B4 (de) * 2004-12-22 2007-03-15 Ta-Xan-Ag Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke
US20090104288A1 (en) * 2006-11-15 2009-04-23 John I. Haas, Inc. Compositions and methods for inhibiting a honey bee pathogen infection or controlling a hive infestation
US20080233221A1 (en) * 2007-03-23 2008-09-25 State Of Oregon Prostate cancer and benign prostatic hyperplasia treatments
EP2249641B1 (en) * 2008-02-27 2016-01-06 Flaxan GmbH & Co. KG Novel compositions containing xanthohumol-cyclodextrin complexes
KR20140032343A (ko) * 2010-10-10 2014-03-14 에릭 쿠르츠 홍조 부작용이 감소된 니아신 제제 및 방법들

Also Published As

Publication number Publication date
WO2014060803A1 (en) 2014-04-24
PL219703B1 (pl) 2015-06-30
US20150283098A1 (en) 2015-10-08
EP2908634A1 (en) 2015-08-26

Similar Documents

Publication Publication Date Title
HUE061255T2 (hu) Stabilizált fluorolefin kompozíciók és eljárások elõállításukra, tárolásukra és felhasználásukra
CL2013002053A1 (es) Compuestos derivados de heterociclicos, antagonistas del receptor de glucagon; composicion farmaceutica que lo comprende y su uso en el tratamiento de diabetes y enfermedades metabolicas. pct
CL2013003287A1 (es) Compuestos derivados de 5-trifluorometil-4,5-dihidro-isoxazol; compuestos intermediarios; procedimiento de preparacion; composiciones farmaceuticas que los comprenden; y uso en el tratamiento de una infestacion de parasitos en animales.
DK3215133T3 (da) Fremgangsmåder og sammensætninger relateret til anvendelsen af overfladeaktive stoffer med lav hlb ved fremstilling af syntetiske nanobærere, som omfatter en rapalog
CY1119974T1 (el) Στερεες μορφες 3-(5-αμινο-2-μεθυλ-4-οξο-4η-κιναζολιν-3-υλ)-πιπεριδινο-2,6-διονης και φαρμακευτικες συνθεσεις και χρησεις αυτης
BRPI0916689A2 (pt) composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida.
CL2013000685A1 (es) Compuestos derivados de n-(fenil/bencil)-6-(1,2,4-oxadiazol-3-il)-1,3,5-triazin-2,4-diamina; bloqueadores de los canales de sodio ( nav 1.7); composicion farmaceutica; que los comprende; uso en el tratamiento del dolor cronico.
DK3350162T3 (da) Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation
HUE061596T2 (hu) Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
EA201600467A1 (ru) Лечение метаболических расстройств у представителей кошачьих
IL244278A0 (en) Cannabinoid compositions, methods of manufacture and use thereof
HUE071411T2 (hu) 2-{4-[N-(5,6-difenilpirazin-2-il)-N-izopropilamino]butiloxi}-N-(metilszulfonil)-acetamidot tartalmazó szilárd gyógyászati készítmény
EP3207928A4 (en) Composite preparation, containing novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseases
JP2016135110A5 (pl)
CL2016002238A1 (es) Compuestos derivados de 3-(5-oxo-4,5-dihidro-1h-tetrazol-1-il)-5,6-dihidropiridin-2(1h)-ona sustituidos con tetrazolona, inhibidores de monocilglicerol aciltransferasa 2 (mgat2); composiciones farmacológicas; útiles para tratar la diabetes, hipeglucemia, intolerancia a la glucosa, resistencia a la insulina, hiperinsulinemia, enfermedad al hígado graso no alcohólico, retinopatía, entre otras.
PL401225A1 (pl) Preparat zapobiegajacy masowemu wymieraniu owadów z rodziny pszczolowatych (Apidae) oraz zastosowania tego preparatu
CL2014001877A1 (es) Mezcla pesticida que incluyen pirrolidindionas espiroheterocíclicas; método para controlar insectos, acáridos, nemátodos o moluscos.
IL285088A (en) Cannabinoid containing composition, methods of preparation and use thereof
EP2975040A4 (en) POLYCYCLIC PYRAZOLINONE DERIVATIVES AND HERBICIDES THEREFORE AS EFFECTIVE COMPONENT OF THEREOF
DK3207023T3 (da) Fremgangsmåde til fremstilling af 1-(3,5-dichlorphenyl)-2,2,2-trifluorethanon og derivater deraf
EP3515891A4 (en) SUBSTITUTED 1-METHYL-1,2,3,4-TETRAHYDROISOCHINOLINE MOLECULES AS ALLOSTERIC PCSK9 BINDERS
FR3008411B1 (fr) Nouveau sel de la 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, sa preparation, et les formulations qui le contiennent
DK3157350T3 (da) Doseringshældeanordning til fedtholdige substanser, navnlig til chokolade
石闻熙 Should Internet New Words Be Used Widely?
รัชต พล ชัย เกียรติ ธรรม Structures of Synonymous Compounds in Central Thai and Lanna Thai